Growth of 17D yellow fever virus in a macrophage-like cell line, U937: role of Fc and viral receptors in antibody-mediated infection. 1981

J J Schlesinger, and M W Brandriss

Growth characteristics of 17D yellow fever virus (17D-YF) and conditions for infection were studied in U937, a macrophage-like, Fc receptor-bearing continuous human cell line. Antibody to 17D-YF was obtained by immunization of normal subjects with 17D-YF vaccine. Cells were infected in the presence or absence of immune whole sera or immunoglobulin fractions. Infection of U937 was temperature dependent; the yield of virus was variable but at low temperature viral titers were consistently higher when infection was established in the presence of antibody. Results of infectious center assays indicated that the increased yield of virus was largely or entirely due to an increase in the number of cells producing virus early in the course of infection. Enhancement of viral growth was mediated by IgG but not IgM fractions of immune sera. Trypsinization of U937 resulted in a 90 to 95% reduction of infection in the absence of antibody but in the presence of antibody viral titers were higher in trypsinized than in nontrypsinized cells. Antibody to 17D-YF, contained in the whole IgG fraction of sera, bound to U937 to mediate infection without first being complexed to virus. Preincubation of U937 with IgG1 but not IgG2 myeloma proteins abrogated antibody-mediated infection. This result is compatible with the known affinities of U937 Fc receptors for specific subclasses of IgG and provides evidence for the role of the Fc receptor in antibody-mediated enhancement of viral growth. Persistent infection characterized by a lack of detectable cytopathogenic effect was established in long-term cultures of U937. This pattern of infection might be related to the unique effectiveness of the 17D-YF vaccine.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D009194 Myeloma Proteins Abnormal immunoglobulins characteristic of MULTIPLE MYELOMA. M Components,Proteins, Myeloma
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D011991 Receptors, Virus Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response. Viral Entry Receptor,Viral Entry Receptors,Virus Attachment Factor,Virus Attachment Factors,Virus Attachment Receptor,Virus Attachment Receptors,Virus Entry Receptor,Virus Entry Receptors,Virus Receptor,Virus Receptors,Attachment Factor, Virus,Attachment Factors, Virus,Attachment Receptor, Virus,Attachment Receptors, Virus,Entry Receptor, Viral,Entry Receptor, Virus,Entry Receptors, Viral,Entry Receptors, Virus,Receptor, Viral Entry,Receptor, Virus,Receptor, Virus Attachment,Receptor, Virus Entry,Receptors, Viral Entry,Receptors, Virus Attachment,Receptors, Virus Entry
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

J J Schlesinger, and M W Brandriss
June 1981, Journal of immunology (Baltimore, Md. : 1950),
J J Schlesinger, and M W Brandriss
March 1988, Journal of medical virology,
J J Schlesinger, and M W Brandriss
August 1988, Microbial pathogenesis,
J J Schlesinger, and M W Brandriss
February 1988, The Journal of general virology,
J J Schlesinger, and M W Brandriss
November 2013, Journal of virology,
J J Schlesinger, and M W Brandriss
January 2019, Emerging microbes & infections,
J J Schlesinger, and M W Brandriss
June 1984, The Journal of general virology,
J J Schlesinger, and M W Brandriss
February 1981, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!